LEMBO, Serena
 Distribuzione geografica
Continente #
NA - Nord America 6.986
AS - Asia 4.848
EU - Europa 4.301
SA - Sud America 593
AF - Africa 75
OC - Oceania 6
Totale 16.809
Nazione #
US - Stati Uniti d'America 6.886
HK - Hong Kong 2.184
IT - Italia 2.010
FI - Finlandia 1.200
SG - Singapore 1.169
CN - Cina 534
BR - Brasile 440
VN - Vietnam 416
RU - Federazione Russa 249
FR - Francia 145
DE - Germania 123
UA - Ucraina 112
IE - Irlanda 111
KR - Corea 107
SE - Svezia 95
TR - Turchia 92
IN - India 90
AR - Argentina 64
NL - Olanda 54
BD - Bangladesh 53
GB - Regno Unito 47
JP - Giappone 42
CA - Canada 41
MX - Messico 33
AT - Austria 26
EC - Ecuador 24
PL - Polonia 24
CO - Colombia 23
IQ - Iraq 23
ES - Italia 22
ID - Indonesia 21
PK - Pakistan 16
VE - Venezuela 15
ZA - Sudafrica 15
CH - Svizzera 14
MY - Malesia 13
PH - Filippine 13
KE - Kenya 10
PY - Paraguay 10
TN - Tunisia 10
UZ - Uzbekistan 10
CZ - Repubblica Ceca 9
EG - Egitto 9
MA - Marocco 9
JM - Giamaica 8
LT - Lituania 8
DZ - Algeria 7
JO - Giordania 7
PE - Perù 7
AE - Emirati Arabi Uniti 6
AU - Australia 6
BE - Belgio 6
SA - Arabia Saudita 6
GR - Grecia 5
HR - Croazia 5
IL - Israele 5
BG - Bulgaria 4
BH - Bahrain 4
CL - Cile 4
DK - Danimarca 4
ET - Etiopia 4
OM - Oman 4
PA - Panama 4
PS - Palestinian Territory 4
AL - Albania 3
BN - Brunei Darussalam 3
DO - Repubblica Dominicana 3
GE - Georgia 3
IR - Iran 3
KW - Kuwait 3
LU - Lussemburgo 3
PT - Portogallo 3
RO - Romania 3
RS - Serbia 3
SN - Senegal 3
UY - Uruguay 3
AO - Angola 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
HU - Ungheria 2
LB - Libano 2
MK - Macedonia 2
MN - Mongolia 2
MU - Mauritius 2
NI - Nicaragua 2
NP - Nepal 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
AF - Afghanistan, Repubblica islamica di 1
BO - Bolivia 1
BY - Bielorussia 1
BZ - Belize 1
CG - Congo 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CU - Cuba 1
CY - Cipro 1
GL - Groenlandia 1
GT - Guatemala 1
GY - Guiana 1
Totale 16.793
Città #
Dallas 2.900
Hong Kong 2.180
Helsinki 1.180
San Jose 564
Singapore 540
Milan 508
Ann Arbor 465
Chandler 339
Princeton 298
Rome 227
Ashburn 212
Woodbridge 207
Houston 158
Council Bluffs 150
Wilmington 136
The Dalles 122
Ho Chi Minh City 120
Lauterbourg 119
Jacksonville 118
Beijing 112
Dublin 107
Moscow 90
Dong Ket 87
Naples 83
Izmir 78
Hanoi 62
New York 61
Salerno 51
Andover 50
Munich 49
Los Angeles 48
Nanjing 46
Boardman 40
São Paulo 40
Pellezzano 39
Turin 38
Tokyo 37
Figino 35
Santa Clara 32
Bari 28
Amsterdam 27
Genoa 25
Nuremberg 25
Seattle 25
Redwood City 24
Stockholm 24
Columbus 23
Hebei 23
Chennai 21
Fairfield 21
Warsaw 21
Bologna 20
Frankfurt am Main 20
Orem 20
Palermo 20
Rio de Janeiro 20
Da Nang 18
Shenyang 18
Brooklyn 17
Denver 17
Fisciano 17
Florence 17
Seoul 17
Changsha 16
London 16
Haiphong 15
Mumbai 15
Norwalk 15
Curitiba 14
Montreal 14
Turku 14
San Francisco 13
Verona 13
Boston 12
Catania 12
Pune 12
Messina 11
Mexico City 11
Napoli 11
Quito 11
Belo Horizonte 10
Cava de' Tirreni 10
Vienna 10
Baghdad 9
Thái Nguyên 9
Albignasego 8
Atlanta 8
Nanchang 8
Phoenix 8
Shanghai 8
Taranto 8
Tashkent 8
Venice 8
West Jordan 8
Brasília 7
Brno 7
Buenos Aires 7
Charlotte 7
Chicago 7
Cinisello Balsamo 7
Totale 12.623
Nome #
058 Oxidative stress in atopic dermatitis and cardiovascular disease: urinary biopyrrins as possible biomarker 3.989
Eruzione cutanea dopo vaccino SARS CoV-2 in paziente psoriasico trattato con MTX 838
A Long-Term Real-Life Safety Study of Guselkumab in Psoriasis Patients with Infectious Comorbidities, Malignancies or Heart Disease: The EARLY Study 479
Real-life experience on effectiveness and safety of dupilumab in adult patients with moderate-to-severe atopic dermatitis 440
Automatic psoriasis assessment methods: Current scenario and perspectives from a metrologic point of view 330
Systemic Treatment of Pediatric Psoriasis: A Review 297
Prevalence, Features and Degree of Association of Oral Lesions in COVID-19: A Systematic Review of Systematic Reviews 247
Psoriasi eritrodermica: rapida efficacia di bimekizumab 212
The anti-inflammatory and antioxidant properties of 1,2-decanediol and willow bark extract in lipopolysaccharide-stimulated keratinocytes 173
An acute spondyloarthritis during successful treatment with dupilumab for severe atopic dermatitis 170
Anti-inflammatory properties of low and high doxycycline doses: An in vitro study 159
Psoriasi e salute del cavo orale: un nesso da non sottovalutare. I primi risultati di uno studio clinico osservazionale 148
Phenolics from Castanea sativa leaves and their effects on UVB-induced damage 143
Farsi promotori di salute: “Safe Sun Coast” 142
IL-36 cytokines are increased in acne and hidradenitis suppurativa 139
Sicurezza ed efficacia di Apremilast in paziente psoriasico oncologico in terapia con pembrolizumab 138
AUF-1 and skin inflammation: atopic dermatitis and psoriasis 130
Psoriasis and bone damage: the role of phosphodiesterase 4 in the pro-osteoclastogenic process induced by skin inflammation. 130
Photodermatoses 127
Effectiveness and Tolerability of a Patch Containing Onion Extract and Allantoin for Cesarean Section Scars 126
Cannabidiol exerts multitarget immunomodulatory effects on PBMCs from individuals with psoriasis vulgaris 123
Understanding the role of haptoglobin in psoriasis: Effects of ultraviolet B 119
A 48-week update of a multicentre real-life experience of dupilumab in adult patients with moderate-to-severe atopic dermatitis 117
The modulatory effect of ellagic acid and rosmarinic acid on ultraviolet-B-induced cytokine/chemokine gene expression in skin keratinocyte (HaCaT) cells 113
Atopic dermatitis: Epidemiology and clinical phenotypes 112
Nicotinamide downregulates gene expression of interleukin-6, interleukin-10, monocyte chemoattractant protein-1, and tumour necrosis factor-α gene expression in HaCaT keratinocytes after ultraviolet B irradiation 110
Anti-tumor necrosis factor-α therapy in the management of psoriasis and B-chronic lymphocytic leukemia 110
Presence of BAG3 protein in serum samples from patients affected by psoriasis 107
Milk thistle and olive extract: old substances with a new mission against sun-induced skin damage 107
Understanding Barriers Impacting upon Patient Wellbeing: A Nationwide Italian Survey and Expert Opinion of Dermatologists Treating Patients with Moderate-to-Severe Psoriasis 105
Fotodermatosi 105
Interleukin-33: increasing role in dermatological conditions 104
Anti-IL-17 therapy rapidly decreases osteoclast activity in psoriatic patients: A novel quality in addition to its efficacy and safety 103
Surprise from skin nodules after travel to South America 102
Toilet contact dermatitis 99
Abnormal isoaspartyl residues in erythrocyte membranes from psoriatic patients 98
Carcinoma basocellulare con invasione perineurale: gestione terapeutica 97
The effect of visible blue light on the differentiation of dendritic cells in vitro 97
Confronto del profilo di efficacia, sicurezza e compliance tra Apremilast, NB-UVB e MTX nei pazienti psoriasici: i primi risultati di uno studio osservazionale multicentrico italiano 95
Polymorphic light eruption and skin cancer prevalence: Is one protective against the other? 94
Aberrant gene expression with deficient apoptotic keratinocyte clearance may predispose to polymorphic light eruption 93
A New Light on the Dark DNA Damages 93
A preterm infant with benign neonatal hemangiomatosis and persistent patent ductus arteriosus: A curious comorbidity 93
Un ingrediente fitoattivo da scarti di Castanea sativa 90
Cancrum oris in a boy with Down syndrome 87
Skin cancer overview. Chapter I: Photodermatoses and skin cancer. 86
AUF-1 and skin inflammation: atopic dermatitis and psoriasis 85
"Pro-osteoclastogenesis march" is induced by cutaneous pro-inflammatory mediators 85
121 Oxidative stress in atopic dermatitis: urinary biopyrrins as possible new biomarker 85
Secukinumab e popolazioni speciali: focus su tubercolosi latente ed epatite virale: studio retrospettivo 85
Lenalidomide-induced psoriasis in a refractory multiple myeloma patient successfully treated with narrowband ultraviolet B 84
Apremilast, NB-UVB e MTX: confronto del profilo di efficacia, di sicurezza e capacità di modulazione dell’infiammazione sistemica nei pazienti psoriasici. Studio osservazionale di coorte prospettico 84
Risankizumab efficacy and safety in psoriatic patients with latent tuberculosis infection: A multicentric real-world study 81
Paraoxonases and psoriasis: negative imbalance of anti--oxidant endogenous mechanisms 80
Psoriasiform dermatitis during dupilumab treatment in atopic patient resolved after combo-therapy with methotrexate 79
IL-33 is regulated by TNF-α in normal and psoriatic skin 79
"Active" photoprotection: Sunscreens with DNA repair enzymes 79
Oral Lesions and Oral Health-Related Quality of Life in Adult Patients with Psoriasis: A Retrospective Chart Review 77
Cutaneous Eruption after SARS-CoV-2 vaccine in psoriatic patient treated with methotrexate 74
Assessing the beneficial impact of a patient support program in secukinumab-treated patients with psoriasis in italy 73
Professional's and non-professional's papular urticaria caused by Scleroderma domesticum 73
Hair whitening in a patient with psoriasis during failure of adalimumab treatment reversed by ixekizumab 73
From the skin to the bone: Pro-osteoclastogenesis inflammatory march 73
PDE4 Inhibition Reduced Osteoclast Differentiation in Psoriatic Patients 72
A severe relapse of pemphigus vulgaris after SARS-CoV-2 vaccination 71
Pizza makers' contact dermatitis 71
IL-26 in allergic contact dermatitis: Resource in a state of readiness 71
Psoriasis in melanoma patients: a prospective pilot study 70
Clinical predictors of psoriatic arthritis and osteoclast differentiation 70
Effects of adalimumab therapy in adult subjects with moderate-to-severe psoriasis on Th17 pathway 69
Mammalian target of rapamycin in inflammatory skin conditions 68
null 67
null 65
Polymorphic light eruption: What's new in pathogenesis and management 65
null 64
Photosensitivity and cancer immune-targeted therapies 64
The important role of interdisciplinary collaboration in the management of a melanocytic skin lesion 64
null 63
Contact sensitization of children referred to the Dermatology Department of the University Federico II of Naples, Italy: a two-decade years history 63
Biologics that inhibit the Th17 pathway and related cytokines to treat inflammatory disorders 61
Real-Life Effectiveness and Safety of Guselkumab in Patients with Psoriasis Who Have an Inadequate Response to Ustekinumab: A 3-Year Multicenter Study 60
null 60
Farmaci biologici e small molecules in dermatite atopica: confronto su efficacia e sugli effetti nella gestione del prurito 59
Effectiveness and safety of secukinumab in Italian patients with psoriasis: an 84 week, multicenter, retrospective real-world study 59
null 58
Predictive Factors for Super Responder Status and Long-Term Effectiveness of Guselkumab in Psoriasis: A Multicenter Retrospective Study 58
Sporotrichosis: long-term treatment and follow-up in a diabetic patient from Southern Italy 57
Immuno-Pathogenesis of Chronic Inflammatory Skin Diseases: Novel Molecular Targets and Biomarkers 56
Crosstalk between skin inflammation and adipose tissue-derived products: pathogenic evidence linking psoriasis to increased adiposity 56
Crack abuse-induced recalcitrant ulcers 56
IL-26: A new actor in allergic contact dermatitis 56
null 55
Disseminated mucocutaneous Candida infection during anti IL-17A therapy in a psoriatic patient 55
Italian National Registry of Alopecia Areata: an epidemiological study of 699 Italian patients 54
Misurazione dinamica degli inquinanti in pazienti affetti da dermatite atopica 54
null 54
Pro-osteoclastogenesis march is enhanced by cutaneous pro-inflammatory mediators 54
null 52
null 52
Dupilumab therapy reduces urinary biopyrrin levels in atopic patients: a new possible biomarker of oxidative status in atopic dermatitis 51
Totale 14.819
Categoria #
all - tutte 49.275
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.275


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022485 2 4 3 12 30 5 5 18 56 47 75 228
2022/2023910 89 64 24 114 86 175 6 103 157 15 51 26
2023/2024688 45 80 38 32 48 54 36 44 21 79 61 150
2024/20251.966 95 39 132 157 93 242 229 124 332 120 186 217
2025/202611.103 302 2.108 3.174 449 661 295 922 250 1.448 610 188 696
2026/202732 32 0 0 0 0 0 0 0 0 0 0 0
Totale 17.043